Immunocore Holdings plc (IMCR) Stock Forecast
Data as of Aug 7, 2026Healthcare · Current price $34.03 (+2.24%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
IMCR vs Sector & Market
| Metric | IMCR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.25 | 2.42 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | +12.5% | +16316.2% | +17.2% |
| P/E Ratio | -54.15 | 3.46 | 35.26 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $109M | $114M | $123M | 4 |
| 2026-12-31 | $112M | $117M | $126M | 7 |
| 2027-03-31 | $113M | $118M | $127M | 4 |
| 2027-06-30 | $116M | $121M | $130M | 6 |
| 2027-09-30 | $121M | $127M | $136M | 4 |
| 2027-12-31 | $130M | $136M | $146M | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.26 | $-0.24 | $-0.22 | 3 |
| 2026-12-31 | $-0.28 | $-0.25 | $-0.24 | 3 |
| 2027-03-31 | $-0.21 | $-0.20 | $-0.18 | 3 |
| 2027-06-30 | $-0.23 | $-0.21 | $-0.20 | 2 |
| 2027-09-30 | $-0.17 | $-0.15 | $-0.14 | 2 |
| 2027-12-31 | $-0.12 | $-0.11 | $-0.11 | 2 |
Frequently Asked Questions
What is the analyst consensus for IMCR?
The consensus among 4 analysts covering Immunocore Holdings plc (IMCR) is Buy with an average price target of $46.50.
What is the highest price target for IMCR?
The highest analyst price target for IMCR is $55.00.
What is the lowest price target for IMCR?
The lowest analyst price target for IMCR is $38.00.
How many analysts cover IMCR?
4 analysts have issued ratings for Immunocore Holdings plc in the past 12 months.
Is IMCR a buy or sell right now?
Based on 4 analyst ratings, IMCR has a consensus rating of Buy (2.25/5) with a +12.5% upside to the consensus target of $46.50.
What are the earnings estimates for IMCR?
Analysts estimate IMCR will report EPS of $-0.24 for the period ending 2026-09-30, with revenue estimated at $114M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.